Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.

By J. Hou, Li Lin, Weiping Zhou, Zhengxin Wang, Guoshan Ding, Q. Dong, L. Qin, Xiaobing Wu, Yuanyuan Zheng, Yun Yang and 9 more. Cancer Cell, 2011

705 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/b9d63cc9104df1bb169ee25cc80bb2ed60d7ba57

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Xuetao Cao

In Molecular Biology

1. Xuetao Cao

Citations in the corpus

• Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans (2011, background): “For HCC, deregulated expression of both proteincoding genes and microRNAs (miRNAs) have been suggested to have considerable potential in predicting the prognosis of HCC patients.(30,31) We found that patients with tumors with high lncRNA-HEIH expression had an increased risk of recurrence and signif”
• Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression (2017, methodology): “Real-time qPCR was performed as described.((13,14)) Glyceraldehyde 3phosphate dehydrogenase was used as the internal control.”